Chicago Cancer Navigation Project

此应用程序的目的是为低收入患者开发患者导航干预 伊利诺伊州芝加哥，前列腺癌、结直肠癌筛查阳性需要后续护理， 乳房和宫颈。我们计划创建一个Patient Navigator程序，它与那些 尽管贫穷，但在报告筛查检测呈阳性后，他们有经济保障获得后续护理。 退伍军人将通过杰西·布朗芝加哥退伍军人管理局和附属的湖滨社区接受后续护理 基于门诊(VA)健康系统(前列腺癌和结直肠癌)和接受 Access社区卫生网络(Access)的护理将通过Medicaid获得后续护理 保险计划(针对乳腺癌和宫颈癌，作为伊利诺伊州乳腺癌和宫颈癌的一部分 《治疗法案》)。拟议的患者导航器将与退伍军人健康密切结合 管理(湖边和西边地点)和准入，公共卫生服务-指定330 具有联邦资格的健康中心组织。这个程序在一定程度上是建立在一个预先存在的导航器上的 计划(来自美国癌症协会/疾病控制中心资助的种族和民族 社区卫生方法(REACH)2010年项目)。2003年，150名退伍军人被诊断出患有 在退伍军人事务部杰西·布朗医学中心，每年有120人被诊断患有前列腺癌和结直肠癌， 而在Access上发现了152名乳腺癌妇女和259名宫颈癌妇女。 通过这项计划，估计有9400名高血压、结直肠癌筛查异常的人， 将导航到颈部和胸部。这项建议的具体目的是：1)提高 在导航器干预站点中进行诊断评估的患者与之前的 性能和通常的护理控制点；2)对于确实得到后续诊断评估的患者 提高异常筛查和最终随访之间的平均诊断解决时间 干预地点与之前的表现和通常的护理控制点进行比较。

The purpose of this application is to develop a patient navigation intervention for lower income patients in Chicago, Illinois, who need follow-up care for positive cancer screening tests of the prostate, colorectum, breast and cervix. We plan to create a patient navigator program, which interfaces with individuals, who although poor, have guaranteed financial access to follow-up care after a positive screening test is reported. Veterans will receive follow-up care through the Jesse Brown Chicago VA and affiliated Lakeside Community Based Outpatient Clinic (VA) health system (forprostate and colorectal cancer) and patients who receive care at Access Community Health Network (ACCESS) will receive follow-up care through the Medicaid insurance program (for breast and cervical cancer, as part of the Illinois Breast and Cervical Cancer Treatment Act). The proposed patient navigator will be closely integrated with the Veterans' Health Administration (Lakeside and Westside locations) and ACCESS, a Public Health Service-designated 330 Federally Qualified Health Center organization. This program is built, in part, upon a pre-existing navigator program (from the American Cancer Society / Centers for Disease Control funded Racial and Ethnic Approaches to Community Health (REACH) 2010 project). In 2003, 150 Veterans were diagnosed with prostate cancer and 120 diagnosed with colorectal cancer each year at the Jesse Brown VA medical center, while 152 women with breast cancer and 259 women with cervical cancer were identified at ACCESS. Through this program it is estimated that 9400 persons with abnormal screening tests for restate, colorectal, cervical and breast will be navigated. The specific aims of this proposal are to: 1) increase the proportion of patients with diagnostic evaluations amongst the navigator interventions sites as compared to both previous performance and the usual care control sites; 2) for patients who do get follow-up diagnostic evaluations to improve mean time to a diagnostic resolution between abnormal screening and definitive follow-up for the intervention sites as compared to both previous performance and to the usual care control sites.